Shanghai, China

Xinxin Wang

This inventor holds 4 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Gracell Biotechnologies (Shanghai) Co., Ltd., Delta Electronics (Shanghai) Co., Ltd., Shanghai Micro Electronics Equipment (Group) Co., Ltd.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinxin Wang. Retrieved from https://idiyas.com/inventor/xinxin-wang-l0nu0fub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Xinxin Wang: Innovator in T Cell Engineering

Introduction

Xinxin Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in T cell engineering. With a total of 4 patents, his work focuses on enhancing the efficacy of immune cells in cancer treatment.

Latest Patents

Wang's latest patents include groundbreaking innovations in engineered immune cells. One of his notable patents is titled "Compositions and methods for T cell engineering." This patent describes an engineered immune cell that comprises a CAR (Chimeric Antigen Receptor) or engineered TCR (T Cell Receptor). The engineered immune cells can inhibit host immune cells, such as T cells and NK cells, thereby enhancing their survival and persistence in vivo. This results in more effective tumor-killing activity. Another significant patent is the "Universal chimeric antigen receptor T-cell preparation technique." This invention provides a universal CAR T cell and its preparation method, which can be used for allogeneic tumor treatment without causing GVHD (Graft Versus Host Disease) and HVG (Host Versus Graft) reactions during infusion. This innovation improves the survival and antineoplastic effect of allogeneic CAR-T cells in recipients.

Career Highlights

Xinxin Wang has worked with notable companies in the biotechnology sector. He has been associated with Gracell Biotechnologies and Shanghai Micro Electronics Equipment Co., Ltd. His experience in these organizations has contributed to his expertise in developing advanced therapeutic techniques.

Collaborations

Wang has collaborated with several professionals in his field, including Zhongdong Shi and Liping Liu. These collaborations have further enriched his research and development efforts in T cell engineering.

Conclusion

Xinxin Wang is a leading inventor whose work in T cell engineering is paving the way for innovative cancer treatments. His patents reflect a commitment to advancing immunotherapy and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…